Skip to content

MCderm

Active
Private limited companyfounded 20223 yrs activeRue de la Croix Hustin 43, 1470 Genappe, BelgiumKBO/BCE: BE 0791.971.346
Summary

MCderm has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €93,337 and a net result of -€39,945. Equity is growing by ~7.8% per year across the filed fiscal years. Its solvency ranks better than 47% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability3▼-97
Solvency85▼-15
Growth52=
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6,000 at 30 days acceptable
Liquidity ample (current ratio 2.64 against 55.33 in 2024; short-term debt: 37.8% and cash: 57.7% of total assets), and 39.9% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
60.1%
Return on assets
-25.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-05-2026, 72 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
72 d early
2024
62 d early
2023
33 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 56 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 May (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

MCderm was incorporated on 6 October 2022 as a Private limited company.1 Total assets rose from EUR 84,398 in 2023 to EUR 155,195 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2023 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€93,337▼ 30.0%
2024 · €133,282
Total assets
€155,195▲ 14.4%
2024 · €135,709
Net result
-€39,945
2024 · €55,348
Working capital
€95,960▼ 27.2%
2024 · €131,900
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the fiscal year before
favourable unfavourable
Line202320242025
Operating result€108,551-€78,236▼ 27.9%€27,937▼ 64.3%
Net result€76,626within the sector's middle half-€55,348within the sector's middle half▼ 27.8%-€39,945below the sector's middle half
Equity€78,793within the sector's middle half-€133,282within the sector's middle half▲ 69.2%€93,337within the sector's middle half▼ 30.0%
Total assets€84,398below the sector's middle half-€135,709within the sector's middle half▲ 60.8%€155,195within the sector's middle half▲ 14.4%
Debt€5,605-€2,428▼ 56.7%€61,858▲ 2,448%
Working capital€78,001within the sector's middle half-€131,900within the sector's middle half▲ 69.1%€95,960within the sector's middle half▼ 27.2%
Solvency93.4%above the sector's middle half-98.2%above the sector's middle half▲ 4.9pp60.1%within the sector's middle half▼ 38.1pp
Current ratio17.23above the sector's middle half-55.33above the sector's middle half▲ 38.102.64within the sector's middle half▼ 52.69
Return on assets (ROA)90.8%above the sector's middle half-40.8%above the sector's middle half▼ 50.0pp-25.7%below the sector's middle half▼ 66.5pp
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€50,000€0€50,000€100,000Operating result 2023: €108,551€108,551Net result 2023: €76,626€76,626Operating result 2024: €78,236€78,236Net result 2024: €55,348€55,348Operating result 2025: €27,937€27,937Net result 2025: -€39,945-€39,945202320242025-€50,000€0€50,000€100,000Operating result 2023: €108,551€109,000Net result 2023: €76,626€76,600Operating result 2024: €78,236€78,200Net result 2024: €55,348€55,300Operating result 2025: €27,937€27,900Net result 2025: -€39,945-€39,900202320242025
The operating result has fallen two years in a row; 2025 is 64% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €155,195
Fixed assets €646 ▼ 53.3%
Current assets €154,549 ▲ 15.1%
Equity and liabilities €155,195
Equity €93,337 ▼ 30.0%
Debt €61,858 ▲ 2,448%
Debt's share of the balance-sheet total rises from 1.8% to 39.9%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€28,673▼
2024 · €78,917
Cash flow
-€39,209▼
2024 · €56,029
Debt to equity
0.66▲
2024 · 0.02
ROE
-42.8%▼
2024 · 41.5%
Interest coverage
0.41▼
2024 · 39.00
Debt ≤ 1 year
€58,589▲
2024 · €2,428
Income taxes
€145▼
2024 · €21,453
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 3,225 companies that looked in July 2024 the way this one looks now, 3.3% went bankrupt within 24 months and 88% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
3.3% went bankrupt
8.7% stopped otherwise
88% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 3,225 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet Code20242025
Assets
Total assets20/58€135,709€155,195▲
Fixed assets21/28€1,382€646▼
Tangible fixed assets22/27€1,382€646▼
Furniture and vehicles24€1,382€646▼
Current assets29/58€134,327€154,549▲
Amounts receivable within one year40/41€12,687€8,293▼
Trade receivables40€601€7,937▲
Other amounts receivable41€12,086€355▼
Current investments50/53€50,123€51,631▲
Cash at bank and in hand54/58€55,245€89,493▲
Deferred charges and accrued income490/1€16,272€5,132▼
Equity and liabilities
Total equity and liabilities10/49€135,709€155,195▲
Equity10/15€133,282€93,337▼
Contributions10/11€3,000€3,000=
Outside capital11€3,000-
Other1109/19€3,000-
Reserves13€130,282€130,282=
Distributable reserves133€130,282€130,282=
Profit (loss) carried forward14--€39,945
Amounts payable17/49€2,428€61,858▲
Amounts payable within one year42/48€2,428€58,589▲
Trade debts44€1,569€233▼
Suppliers440/4€1,569€233▼
Other amounts payable47/48€859€58,356▲
Accrued charges and deferred income492/3-€3,269
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€682€736▲
Other operating charges640/8€381€789▲
Gross operating margin9900€79,298€29,462▼
Operating profit (loss)9901€78,236€27,937▼
Financial income75/76B€589€1,795▲
Recurring financial income75€589€1,795▲
Financial charges65/66B€2,024€69,532▲
Recurring financial charges65€2,024€69,532▲
Profit (loss) for the period before taxes9903€76,801-€39,800▼
Income taxes67/77€21,453€145▼
Profit (loss) for the period9904€55,348-€39,945▼
Profit (loss) for the period to be appropriated9905€55,348-€39,945▼
Appropriation of the result
Profit (loss) to be appropriated9906€55,348-€39,945▼
Transfer to equity691/2€54,489-
To other reserves6921€54,489-
Profit to be distributed694/7€859-
Return on contributions (dividend)694€859-

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€144€682€736▲ 7.9%
Other operating charges640/8€1,591€381€789▲ 107%
Gross operating margin9900€110,286€79,298€29,462▼ 62.8%
Operating profit (loss)9901€108,551€78,236€27,937▼ 64.3%
Financial income75/76B-€589€1,795▲ 205%
Recurring financial income75-€589€1,795▲ 205%
Financial charges65/66B€1,756€2,024€69,532▲ 3,336%
Recurring financial charges65€1,756€2,024€69,532▲ 3,336%
Profit (loss) for the period before taxes9903€106,795€76,801-€39,800▼ 152%
Income taxes67/77€30,169€21,453€145▼ 99.3%
Profit (loss) for the period9904€76,626€55,348-€39,945▼ 172%
Profit (loss) for the period to be appropriated9905€76,626€55,348-€39,945▼ 172%
Line202320242025Change
Assets
Total assets20/58€84,398€135,709€155,195▲ 14.4%
Fixed assets21/28€1,592€1,382€646▼ 53.3%
Tangible fixed assets22/27€1,592€1,382€646▼ 53.3%
Furniture and vehicles24€1,592€1,382€646▼ 53.3%
Current assets29/58€82,806€134,327€154,549▲ 15.1%
Amounts receivable within one year40/41€631€12,687€8,293▼ 34.6%
Trade receivables40-€601€7,937▲ 1,221%
Other amounts receivable41€631€12,086€355▼ 97.1%
Current investments50/53-€50,123€51,631▲ 3.0%
Cash at bank and in hand54/58€64,749€55,245€89,493▲ 62.0%
Deferred charges and accrued income490/1€17,426€16,272€5,132▼ 68.5%
Equity and liabilities
Total equity and liabilities10/49€84,398€135,709€155,195▲ 14.4%
Equity10/15€78,793€133,282€93,337▼ 30.0%
Contributions10/11€3,000€3,000€3,000=
Outside capital11-€3,000--
Other1109/19-€3,000--
Reserves13€75,793€130,282€130,282=
Distributable reserves133€75,793€130,282€130,282=
Profit (loss) carried forward14---€39,945-
Amounts payable17/49€5,605€2,428€61,858▲ 2,448%
Amounts payable within one year42/48€4,805€2,428€58,589▲ 2,313%
Trade debts44€1,506€1,569€233▼ 85.2%
Suppliers440/4€1,506€1,569€233▼ 85.2%
Other amounts payable47/48€3,300€859€58,356▲ 6,693%
Accrued charges and deferred income492/3€800-€3,269-
Line202320242025Change
Profit (loss) for the period9904€76,626€55,348-€39,945▼ 172%
+ Depreciation and write-downs630€144€682€736▲ 7.9%
Operating cash flow (approximation)€76,770€56,029-€39,209▼ 170%
Investment in fixed assets (approximation)--€472€0▲ 100%
Change in cash--€9,504€34,248▲ 460%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
20-05
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Weakest financial yearnet -€39,945
Net result drops to -€39,945, the lowest in the series.
30-05
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Liquidity triplescurrent ratio 55.33
Current ratio from 17.23 to 55.33; short-term debt falls from €4,805 to €2,428.
31-12
Financial Equity above €100,000Eq €133,282 ▲69.2%
2 profitable years in a row build equity to €133,282.
28-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 1 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Genappe · 1 establishment unit since 2022
seat establishment The establishment unit on the map
Ground area
743 m²
Building footprint
90 m²
Volume, LiDAR
582 m³
Parcel 25003D0009/00X000, Wallonia · tallest building 7.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
MCderm
Rue de la Croix Hustin 43, 1470 GenappeSpecialist medical practice
since 20222.336.668.929
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25003D0009/00X000 Wallonia 743 m² 1 · 90 m² 7.6 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

254900G40QV8SUWVYU84
live in the LEI register

Similar companies · same sector, comparable size

Of 16,625 companies in this sector we hold annual accounts for 7,989. 6,209 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPrivate limited company
Founded06-10-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0791971346
Also 9925:BE0791971346
Registered 08-01-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.